Page last updated: 2024-11-03

prazosin and Hematuria

prazosin has been researched along with Hematuria in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Hematuria: Presence of blood in the urine.

Research Excerpts

ExcerptRelevanceReference
"We evaluated the effect of terazosin in the improvement of lower urinary tract symptoms and flank pain in patients with internal ureteral stents."5.15Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial. ( Esmaeili, S; Farzan, A; Ghodsi, S; Heidari Nejad, S; Mokhtari, G; Shakiba, M, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mokhtari, G1
Shakiba, M1
Ghodsi, S1
Farzan, A1
Heidari Nejad, S1
Esmaeili, S1

Trials

1 trial available for prazosin and Hematuria

ArticleYear
Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial.
    Urologia internationalis, 2011, Volume: 87, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Chi-Square Distribution; Double-Blind Method; Flank Pain; H

2011